Last week, the Los Angeles Times reported on the number of clinical trials that are postponed because enrollment numbers have not been met. And a March 10 Newsweek story looked at the types of social media networks that pharmaceutical companies are tapping into to recruit patients.
While Facebook and Web sites have been two major ways for pharmaceutical or biotechnology companies to recruit patients, one firm is eying Twitter - specifically because it is already a public forum, unlike a private Facebook page, says Carmen Gonzalez, manager of strategy and communications for Healthcare Communications Group.
"It's a way to cut through the noise," she notes.
The clinical trial recruitment firm recently drafted a set of guidelines to provide to clients who are considering Twitter as a part of their strategy.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister